488(top 0.1%)
PR articles
17.7K(top 1%)
PR citations
67(top 1%)
PR h-index
72(top 1%)
h-index
501
documents
21.2K
doc citations
3.6K
citing journals
100
times ranked

Publications

494 peer-reviewed articles • 19,059 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Cannabinerol Restores mRNA Splicing Defects Induced by β-Amyloid in an In Vitro Model of Alzheimer’s Disease: A Transcriptomic Study4.44Citations (PDF)
2Cannabinol’s Modulation of Genes Involved in Oxidative Stress Response and Neuronal Plasticity: A Transcriptomic Analysis
Antioxidants, 2025, 14, 744
5.80Citations (PDF)
3Glucosinolate Metabolites and Brain Health: An Updated Review on Their Potential Benefits in Neurodegenerative, Neurodevelopmental, and Psychiatric Disorders
Antioxidants, 2025, 14, 818
5.86Citations (PDF)
4α-Cyclodextrin/Moringin Impacts Actin Cytoskeleton Dynamics with Potential Implications for Synaptic Organization: A Preliminary Transcriptomic Study in NSC-34 Motor Neurons4.40Citations (PDF)
5Computational Splicing Analysis of Transcriptomic Data Reveals Sulforaphane Modulation of Alternative mRNA Splicing of DNA Repair Genes in Differentiated SH-SY5Y Neurons4.41Citations (PDF)
6Erratum to “Natural almond skin reduced oxidative stress and inflammation in an experimental model of inflammatory bowel disease” [Int. Immunopharmacol. 11(8) (2011) 915–924]4.20Citations (PDF)
7Network Analysis Performed on Transcriptomes of Parkinson’s Disease Patients Reveals Dysfunction in Protein Translation4.44Citations (PDF)
8Cannabinerol (CBNR) Influences Synaptic Genes Associated with Cytoskeleton and Ion Channels in NSC-34 Cell Line: A Transcriptomic Study
Biomedicines, 2024, 12, 189
3.42Citations (PDF)
9Corrigendum to “Protective effects of Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP), a superoxide dismutase mimetic, in paw oedema induced by carrageenan in the rat’’ [Biochem. Pharmacol. 58(1) (1999) 171–176]
Biochemical Pharmacology, 2024, 220, 115986
5.10Citations (PDF)
10Innovative Insights into Traumatic Brain Injuries: Biomarkers and New Pharmacological Targets4.442Citations (PDF)
11Corrigendum to “Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase, in a rodent model of lung injury“ [Biochem. Pharmacol. 63(1) (2002) 293–304]
Biochemical Pharmacology, 2024, 223, 116099
5.10Citations (PDF)
12In Silico Analysis Highlights Potential Predictive Indicators Associated with Secondary Progressive Multiple Sclerosis4.41Citations (PDF)
13Retraction notice to “Glycogen synthase kinase-3β inhibition attenuates the degree of arthritis caused by type II collagen in the mouse” [Clin. Immunol. 120/1 (2006) 57–67]
Clinical Immunology, 2024, 262, 110198
2.60Citations (PDF)
14Retraction notice to “Prevention of carrageenan-induced pleurisy in mice by anti-CD30 ligand monoclonal antibody” [Clin. Immunol. 113/1 (2004) 64–73]
Clinical Immunology, 2024, 262, 110197
2.60Citations (PDF)
15Cannabinerol Prevents Endoplasmic Reticulum and Mitochondria Dysfunctions in an In Vitro Model of Alzheimer’s Disease: A Network-Based Transcriptomic Analysis
Cells, 2024, 13, 1012
4.63Citations (PDF)
16Cannabinol Regulates the Expression of Cell Cycle-Associated Genes in Motor Neuron-like NSC-34: A Transcriptomic Analysis
Biomedicines, 2024, 12, 1340
3.42Citations (PDF)
17α-Cyclodextrin/Moringin Induces an Antioxidant Transcriptional Response Activating Nrf2 in Differentiated NSC-34 Motor Neurons
Antioxidants, 2024, 13, 813
5.82Citations (PDF)
18Artificial Intelligence and Heart-Brain Connections: A Narrative Review on Algorithms Utilization in Clinical Practice
Healthcare (Switzerland), 2024, 12, 1380
2.18Citations (PDF)
19Estrogen Receptors: A New Frontier in Alzheimer’s Disease Therapy4.421Citations (PDF)
20Bioactivated Glucoraphanin Modulates Genes Involved in Necroptosis on Motor-Neuron-like Nsc-34: A Transcriptomic Study
Antioxidants, 2024, 13, 1111
5.81Citations (PDF)
21Cannabinol (CBN) Influences the Ion Channels and Synaptic-Related Genes in NSC-34 Cell Line: A Transcriptomic Study
Cells, 2024, 13, 1573
4.69Citations (PDF)
22Bioactivated Glucoraphanin Improves Cell Survival, Upregulating Phospho-AKT, and Modulates Genes Involved in DNA Repair in an In Vitro Alzheimer’s Disease Model: A Network-Transcriptomic Analysis
Nutrients, 2024, 16, 4202
4.47Citations (PDF)
23Nrf2 Activation: Involvement in Central Nervous System Traumatic Injuries. A Promising Therapeutic Target of Natural Compounds4.429Citations (PDF)
24State of the Art and Future of Stem Cell Therapy in Ischemic Stroke: Why Don’t We Focus on Their Administration?
Bioengineering, 2023, 10, 118
3.24Citations (PDF)
25Regenerative Effects of Exosomes-Derived MSCs: An Overview on Spinal Cord Injury Experimental Studies
Biomedicines, 2023, 11, 201
3.424Citations (PDF)
26Cannabigerol Activates Cytoskeletal Remodeling via Wnt/PCP in NSC-34: An In Vitro Transcriptional Study
Plants, 2023, 12, 193
3.61Citations (PDF)
27A Comprehensive Exploration of the Transcriptomic Landscape in Multiple Sclerosis: A Systematic Review4.414Citations (PDF)
28miRNAs and Alzheimer’s Disease: Exploring the Role of Inflammation and Vitamin E in an Old-Age Population
Nutrients, 2023, 15, 634
4.420Citations (PDF)
29MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s Disease4.428Citations (PDF)
30Cannabichromene Induces Neuronal Differentiation in NSC-34 Cells: Insights from Transcriptomic Analysis
Life, 2023, 13, 742
2.62Citations (PDF)
31Δ8-THC Protects against Amyloid Beta Toxicity Modulating ER Stress In Vitro: A Transcriptomic Analysis4.416Citations (PDF)
32Δ8-THC Induces Up-Regulation of Glutamatergic Pathway Genes in Differentiated SH-SY5Y: A Transcriptomic Study4.46Citations (PDF)
33An In Silico Analysis Reveals Sustained Upregulation of Neuroprotective Genes in the Post-Stroke Human Brain
Brain Sciences, 2023, 13, 986
2.42Citations (PDF)
34Transcriptome Highlights Cannabinol Modulation of Mitophagy in a Parkinson’s Disease In Vitro Model
Biomolecules, 2023, 13, 1163
4.28Citations (PDF)
35Transcriptomic Profiling after In Vitro Δ8-THC Exposure Shows Cytoskeletal Remodeling in Trauma-Injured NSC-34 Cell Line
Pharmaceuticals, 2023, 16, 1268
4.21Citations (PDF)
36In Silico Analysis Reveals the Modulation of Ion Transmembrane Transporters in the Cerebellum of Alzheimer’s Disease Patients4.42Citations (PDF)
37Modulating Stress Proteins in Response to Therapeutic Interventions for Parkinson’s Disease4.413Citations (PDF)
38Corrigendum to “Ibuprofen-arginine generates nitric oxide and has enhanced anti-inflammatory effects” [Pharmacol. Res. 60 (2009) 159–169]
Pharmacological Research, 2023, 198, 107002
9.10Citations (PDF)
39Will Cannabigerol Trigger Neuroregeneration after a Spinal Cord Injury? An In Vitro Answer from NSC-34 Scratch-Injured Cells Transcriptome
Pharmaceuticals, 2022, 15, 117
4.210Citations (PDF)
40Beneficial Health Effects of Glucosinolates-Derived Isothiocyanates on Cardiovascular and Neurodegenerative Diseases
Molecules, 2022, 27, 624
4.2103Citations (PDF)
41MiR-155: An Important Regulator of Neuroinflammation4.4145Citations (PDF)
42Mesenchymal Stromal Cells Preconditioning: A New Strategy to Improve Neuroprotective Properties4.415Citations (PDF)
43Aducanumab and Its Effects on Tau Pathology: Is This the Turning Point of Amyloid Hypothesis?4.435Citations (PDF)
44Potential Anti-Inflammatory Effects of a New Lyophilized Formulation of the Conditioned Medium Derived from Periodontal Ligament Stem Cells
Biomedicines, 2022, 10, 683
3.46Citations (PDF)
45Sphingolipid Metabolism as a New Predictive Target Correlated with Aging and AD: A Transcriptomic Analysis
Medicina (Lithuania), 2022, 58, 493
2.07Citations (PDF)
46Dental Mesenchymal Stem Cell Secretome: An Intriguing Approach for Neuroprotection and Neuroregeneration4.448Citations (PDF)
47Artificial Intelligence Predictor for Alzheimer’s Disease Trained on Blood Transcriptome: The Role of Oxidative Stress4.411Citations (PDF)
48The Role of Hypoxia in Improving the Therapeutic Potential of Mesenchymal Stromal Cells. A Comparative Study From Healthy Lung and Congenital Pulmonary Airway Malformations in Infants4.04Citations (PDF)
49Serum-Free Cultures: Could They Be a Future Direction to Improve Neuronal Differentiation of Mesenchymal Stromal Cells?4.420Citations (PDF)
50Cannabinerol and NSC-34 Transcriptomic Analysis: Is the Dose Who Makes Neuronal Differentiation?4.44Citations (PDF)
51Can a Scaffold Enriched with Mesenchymal Stem Cells Be a Good Treatment for Spinal Cord Injury?4.417Citations (PDF)
52MiRNAs as Promising Translational Strategies for Neuronal Repair and Regeneration in Spinal Cord Injury
Cells, 2022, 11, 2177
4.644Citations (PDF)
53The Role of Cytotoxic T-Lymphocyte Antigen 4 in the Pathogenesis of Multiple Sclerosis
Genes, 2022, 13, 1319
2.512Citations (PDF)
54Inosine in Neurodegenerative Diseases: From the Bench to the Bedside
Molecules, 2022, 27, 4644
4.230Citations (PDF)
55Does Childhood Obesity Trigger Neuroinflammation?
Biomedicines, 2022, 10, 1953
3.410Citations (PDF)
56Cannabidiol Promotes Neuronal Differentiation Using Akt and Erk Pathways Triggered by Cb1 Signaling
Molecules, 2022, 27, 5644
4.29Citations (PDF)
57The Role of Cannabinoid Type 2 Receptors in Parkinson’s Disease
Biomedicines, 2022, 10, 2986
3.415Citations (PDF)
58Reactive Oxygen Species and Their Impact in Neurodegenerative Diseases: Literature Landscape Analysis6.3105Citations (PDF)
59A State of the Art of Antioxidant Properties of Curcuminoids in Neurodegenerative Diseases4.436Citations (PDF)
60Temporomandibular Disorders Slow Down the Regeneration Process of Masticatory Muscles: Transcriptomic Analysis
Medicina (Lithuania), 2021, 57, 354
2.07Citations (PDF)
61Oral Bone Tissue Regeneration: Mesenchymal Stem Cells, Secretome, and Biomaterials4.4101Citations (PDF)
62The Moringin/α-CD Pretreatment Induces Neuroprotection in an In Vitro Model of Alzheimer’s Disease: A Transcriptomic Study2.723Citations (PDF)
63NOX2 Activation in COVID-19: Possible Implications for Neurodegenerative Diseases
Medicina (Lithuania), 2021, 57, 604
2.029Citations (PDF)
64SARS-CoV-2 Infected Pediatric Cerebral Cortical Neurons: Transcriptomic Analysis and Potential Role of Toll-like Receptors in Pathogenesis4.416Citations (PDF)
65Role of Quercetin in Depressive-Like Behaviors: Findings from Animal Models2.138Citations (PDF)
66Transcriptomic Analysis of HCN-2 Cells Suggests Connection among Oxidative Stress, Senescence, and Neuron Death after SARS-CoV-2 Infection
Cells, 2021, 10, 2189
4.617Citations (PDF)
67Ginger, a Possible Candidate for the Treatment of Dementias?
Molecules, 2021, 26, 5700
4.225Citations (PDF)
68MicroRNA Profiling of HL-1 Cardiac Cells-Derived Extracellular Vesicles
Cells, 2021, 10, 273
4.69Citations (PDF)
69Discovering Genotype Variants in an Infant with VACTERL through Clinical Exome Sequencing: A Support for Personalized Risk Assessment and Disease Prevention
Pediatric Reports, 2021, 13, 45-56
1.34Citations (PDF)
70Cannabinoids and Neurogenesis: The Promised Solution for Neurodegeneration?
Molecules, 2021, 26, 6313
4.223Citations (PDF)
71Transcriptomic analysis revealed increased expression of genes involved in keratinization in the tears of COVID-19 patients
Scientific Reports, 2021, 11,
3.416Citations (PDF)
72MiRNA: Involvement of the MAPK Pathway in Ischemic Stroke. A Promising Therapeutic Target
Medicina (Lithuania), 2021, 57, 1053
2.041Citations (PDF)
73SARS-CoV-2 Exposed Mesenchymal Stromal Cell from Congenital Pulmonary Airway Malformations: Transcriptomic Analysis and the Expression of Immunomodulatory Genes4.43Citations (PDF)
74Determining oncogenic patterns and cancer predisposition through the transcriptomic profile in Mitchell–Riley syndrome with heterotopic gastric mucosa and duodenal atresia: a case report3.18Citations (PDF)
75Proliferation Pattern of Pediatric Tumor-Derived Mesenchymal Stromal Cells and Role in Cancer Dormancy: A Perspective of Study for Surgical Strategy1.73Citations (PDF)
76Mesenchymal Stromal Cells for the Treatment of Interstitial Lung Disease in Children: A Look from Pediatric and Pediatric Surgeon Viewpoints
Cells, 2021, 10, 3270
4.614Citations (PDF)
77SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer’s Disease Patients4.452Citations (PDF)
78Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches4.547Citations (PDF)
79In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod
Molecules, 2020, 25, 20
4.227Citations (PDF)
80The Transcriptomic Analysis of NSC-34 Motor Neuron-Like Cells Reveals That Cannabigerol Influences Synaptic Pathways: A Comparative Study with Cannabidiol
Life, 2020, 10, 227
2.615Citations (PDF)
81Activation of Nrf2 by Natural Bioactive Compounds: A Promising Approach for Stroke?4.476Citations (PDF)
82Efficacy of Sulforaphane in Neurodegenerative Diseases4.4159Citations (PDF)
83Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies4.476Citations (PDF)
84Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease
Molecules, 2020, 25, 5186
4.275Citations (PDF)
85Inflammation in Obesity-Related Complications in Children: The Protective Effect of Diet and Its Potential Role as a Therapeutic Agent
Biomolecules, 2020, 10, 1324
4.266Citations (PDF)
86MicroRNAs Modulate the Pathogenesis of Alzheimer’s Disease: An In Silico Analysis in the Human Brain
Genes, 2020, 11, 983
2.520Citations (PDF)
87In Vitro-Transcribed mRNA Chimeric Antigen Receptor T Cell (IVT mRNA CAR T) Therapy in Hematologic and Solid Tumor Management: A Preclinical Update4.465Citations (PDF)
88Tunneling Nanotubes-Mediated Protection of Mesenchymal Stem Cells: An Update from Preclinical Studies4.435Citations (PDF)
89Functional Relationship between Osteogenesis and Angiogenesis in Tissue Regeneration4.4371Citations (PDF)
90Prenatal Hypoxia and Placental Oxidative Stress: Insights from Animal Models to Clinical Evidences
Antioxidants, 2020, 9, 414
5.849Citations (PDF)
91Enhanced VEGF/VEGF-R and RUNX2 Expression in Human Periodontal Ligament Stem Cells Cultured on Sandblasted/Etched Titanium Disk3.648Citations (PDF)
92Could the Heat Shock Proteins 70 Family Members Exacerbate the Immune Response in Multiple Sclerosis? An in Silico Study
Genes, 2020, 11, 615
2.522Citations (PDF)
93Extracellular Vesicles of Human Periodontal Ligament Stem Cells Contain MicroRNAs Associated to Proto-Oncogenes: Implications in Cytokinesis2.326Citations (PDF)
94The cytokine network in the pathogenesis of major depressive disorder. Close to translation?
Autoimmunity Reviews, 2020, 19, 102504
7.182Citations (PDF)
95Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT/mTOR pathway
Fìtoterapìâ, 2020, 143, 104553
2.572Citations (PDF)
96Traumatic Brain Injury and Stem Cells: An Overview of Clinical Trials, the Current Treatments and Future Therapeutic Approaches
Medicina (Lithuania), 2020, 56, 137
2.047Citations (PDF)
97Could the Enrichment of a Biomaterial with Conditioned Medium or Extracellular Vesicles Modify Bone-Remodeling Kinetics during a Defect Healing? Evaluations on Rat Calvaria with Synchrotron-Based Microtomography2.17Citations (PDF)
98Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson’s Disease4.437Citations (PDF)
99Neuroprotective Mechanisms of Three Natural Antioxidants on a Rat Model of Parkinson’s Disease: A Comparative Study
Antioxidants, 2020, 9, 49
5.840Citations (PDF)
100Impaired Expression of Tetraspanin 32 (TSPAN32) in Memory T Cells of Patients with Multiple Sclerosis
Brain Sciences, 2020, 10, 52
2.421Citations (PDF)
101Stem Cells Therapy for Spinal Cord Injury: An Overview of Clinical Trials4.487Citations (PDF)
102N-Acetylcysteine causes analgesia in a mouse model of painful diabetic neuropathy
Molecular Pain, 2020, 16,
2.426Citations (PDF)
103Extracellular Vesicles Derived from Human Gingival Mesenchymal Stem Cells: A Transcriptomic Analysis
Genes, 2020, 11, 118
2.557Citations (PDF)
104Salivary Biomarkers: Future Approaches for Early Diagnosis of Neurodegenerative Diseases
Brain Sciences, 2020, 10, 245
2.439Citations (PDF)
105Transcriptomic analysis reveals moderate modulation of macrophage migration inhibitory factor superfamily genes in alcohol use disorders2.05Citations (PDF)
106Retrospective follow-up analysis of the transcriptomic patterns of cytokines, cytokine receptors and chemokines at preconception and during pregnancy, in women with post-partum depression2.027Citations (PDF)
107β-Caryophyllene Mitigates Collagen Antibody Induced Arthritis (CAIA) in Mice Through a Cross-Talk between CB2 and PPAR-γ Receptors
Biomolecules, 2019, 9, 326
4.270Citations (PDF)
1083D Printing PLA/Gingival Stem Cells/ EVs Upregulate miR-2861 and -210 during Osteoangiogenesis Commitment4.4100Citations (PDF)
109Characterization of the Pathophysiological Role of CD47 in Uveal Melanoma
Molecules, 2019, 24, 2450
4.233Citations (PDF)
110Upregulation of IL-1 Receptor Antagonist in a Mouse Model of Migraine
Brain Sciences, 2019, 9, 172
2.430Citations (PDF)
111Autism Spectrum Disorder and miRNA: An Overview of Experimental Models
Brain Sciences, 2019, 9, 265
2.429Citations (PDF)
112Upregulated Expression of Macrophage Migration Inhibitory Factor, Its Analogue D-Dopachrome Tautomerase, and the CD44 Receptor in Peripheral CD4 T Cells from Clinically Isolated Syndrome Patients with Rapid Conversion to Clinical Defined Multiple Sclerosis
Medicina (Lithuania), 2019, 55, 667
2.029Citations (PDF)
113Overexpression of Macrophage Migration Inhibitory Factor and Its Homologue D-Dopachrome Tautomerase as Negative Prognostic Factor in Neuroblastoma
Brain Sciences, 2019, 9, 284
2.435Citations (PDF)
114Role of miRNAs in Alzheimer’s Disease and Possible Fields of Application4.4106Citations (PDF)
115Neuroprotective Potential of Secondary Metabolites from Melicope lunu-ankenda (Rutaceae)
Molecules, 2019, 24, 3109
4.218Citations (PDF)
116Prediction of PD-L1 Expression in Neuroblastoma via Computational Modeling
Brain Sciences, 2019, 9, 221
2.426Citations (PDF)
117Modulation of Tetraspanin 32 (TSPAN32) Expression in T Cell-Mediated Immune Responses and in Multiple Sclerosis4.432Citations (PDF)
118Moringin Pretreatment Inhibits the Expression of Genes Involved in Mitophagy in the Stem Cell of the Human Periodontal Ligament
Molecules, 2019, 24, 3217
4.230Citations (PDF)
119α-Tocopherol Modulates Non-Amyloidogenic Pathway and Autophagy in an In Vitro Model of Alzheimer’s Disease: A Transcriptional Study
Brain Sciences, 2019, 9, 196
2.428Citations (PDF)
120The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials
Cell Transplantation, 2019, 28, 1507-1527
2.7176Citations (PDF)
121Engineered Extracellular Vesicles From Human Periodontal-Ligament Stem Cells Increase VEGF/VEGFR2 Expression During Bone Regeneration2.8125Citations (PDF)
122Migraine: Experimental Models and Novel Therapeutic Approaches4.450Citations (PDF)
123Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing‑remitting multiple sclerosis to natalizumab treatment2.829Citations (PDF)
124Transcriptomic Analysis of MAPK Signaling in NSC-34 Motor Neurons Treated with Vitamin E
Nutrients, 2019, 11, 1081
4.413Citations (PDF)
125Moringin from Moringa Oleifera Seeds Inhibits Growth, Arrests Cell-Cycle, and Induces Apoptosis of SH-SY5Y Human Neuroblastoma Cells through the Modulation of NF-κB and Apoptotic Related Factors4.467Citations (PDF)
126Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF
Journal of Neuroimmunology, 2019, 332, 224-232
2.332Citations (PDF)
127Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
Molecules, 2019, 24, 1459
4.2166Citations (PDF)
128Periodontal Ligament Stem Cells: Current Knowledge and Future Perspectives
Stem Cells and Development, 2019, 28, 995-1003
2.0176Citations (PDF)
129Physiological Expression of Ion Channel Receptors in Human Periodontal Ligament Stem Cells
Cells, 2019, 8, 219
4.64Citations (PDF)
130Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis?
Stem Cells International, 2019, 2019, 1-16
4.056Citations (PDF)
131Human gingival mesenchymal stem cells pretreated with vesicular moringin nanostructures as a new therapeutic approach in a mouse model of spinal cord injury3.560Citations (PDF)
132Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo
Investigational New Drugs, 2019, 37, 1014-1028
2.547Citations (PDF)
133Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets2.651Citations (PDF)
134Effects of Treatment with the Hypomethylating Agent 5-aza-2′-deoxycytidine in Murine Type II Collagen-Induced Arthritis
Pharmaceuticals, 2019, 12, 174
4.220Citations (PDF)
135Transcriptomic Analysis Reveals Involvement of the Macrophage Migration Inhibitory Factor Gene Network in Duchenne Muscular Dystrophy
Genes, 2019, 10, 939
2.519Citations (PDF)
136Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol
Medicina (Lithuania), 2019, 55, 747
2.069Citations (PDF)
137Transcriptomic Analysis of Stem Cells Treated with Moringin or Cannabidiol: Analogies and Differences in Inflammation Pathways4.430Citations (PDF)
138The Role of Hypoxia on the Neuronal Differentiation of Gingival Mesenchymal Stem Cells: A Transcriptional Study
Cell Transplantation, 2019, 28, 538-552
2.721Citations (PDF)
139Differential modulation and prognostic values of immune-escape genes in uveal melanoma
PLoS ONE, 2019, 14, e0210276
2.353Citations (PDF)
140Heavy metal intoxication and amyotrophic lateral sclerosis: causal or casual relationship?2.73Citations (PDF)
141Wolfram syndrome 1 in the Italian population: genotype–phenotype correlations
Pediatric Research, 2019, 87, 456-462
2.233Citations (PDF)
142Eruca sativa seed extract: A novel natural product able to counteract neuroinflammation2.822Citations (PDF)
143Biomarkers identification for PML monitoring, during Natalizumab (Tysabri®) treatment in Relapsing-Remitting Multiple Sclerosis2.23Citations (PDF)
144Three-dimensional printed PLA scaffold and human gingival stem cell-derived extracellular vesicles: a new tool for bone defect repair6.6245Citations (PDF)
145Transcriptomic analysis of gingival mesenchymal stem cells cultured on 3D bioprinted scaffold: A promising strategy for neuroregeneration4.249Citations (PDF)
146The H2S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide
Molecules, 2018, 23, 2966
4.225Citations (PDF)
147Overview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases
Molecules, 2018, 23, 3305
4.2266Citations (PDF)
148Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells
Molecules, 2018, 23, 2463
4.238Citations (PDF)
149The plasminogen binding protein PbsP is required for brain invasion by hypervirulent CC17 Group B streptococci3.436Citations (PDF)
150A case report of recessive myotonia congenita and early onset cognitive impairment
Medicine (United States), 2018, 97, e10785
1.22Citations (PDF)
151Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences
Journal of Neuroimmunology, 2018, 322, 46-56
2.377Citations (PDF)
152Activation of A2A Receptor by PDRN Reduces Neuronal Damage and Stimulates WNT/β-CATENIN Driven Neurogenesis in Spinal Cord Injury3.864Citations (PDF)
153Biotherapeutic Effect of Gingival Stem Cells Conditioned Medium in Bone Tissue Restoration4.481Citations (PDF)
154Biofunctionalized Scaffold in Bone Tissue Repair4.475Citations (PDF)
155In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid4.495Citations (PDF)
156Isothiocyanates: An Overview of Their Antimicrobial Activity against Human Infections
Molecules, 2018, 23, 624
4.2205Citations (PDF)
157Protective Effect of Glucosinolates Hydrolytic Products in Neurodegenerative Diseases (NDDs)
Nutrients, 2018, 10, 580
4.462Citations (PDF)
158Gasotransmitters and the immune system: Mode of action and novel therapeutic targets4.363Citations (PDF)
159The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets4.4165Citations (PDF)
160A Combined Approach of NMR and Mass Spectrometry Techniques Applied to the α-Cyclodextrin/Moringin Complex for a Novel Bioactive Formulation †
Molecules, 2018, 23, 1714
4.225Citations (PDF)
161In vitro cytotoxicity evaluation of cadmium by label‐free holographic microscopy2.028Citations (PDF)
162Treatment of Periodontal Ligament Stem Cells with MOR and CBD Promotes Cell Survival and Neuronal Differentiation via the PI3K/Akt/mTOR Pathway4.444Citations (PDF)
163The α-Cyclodextrin/Moringin Complex: A New Promising Antimicrobial Agent against Staphylococcus aureus
Molecules, 2018, 23, 2097
4.216Citations (PDF)
164Overexpression of macrophage migration inhibitory factor and functionally‑related genes, D‑DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma1.955Citations (PDF)
165When dysphoria is not a primary mental state
Medicine (United States), 2018, 97, e10953
1.28Citations (PDF)
166Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis
Journal of Neuroimmunology, 2018, 321, 41-48
2.320Citations (PDF)
167Moringin Induces Neural Differentiation in the Stem Cell of the Human Periodontal Ligament3.433Citations (PDF)
168Mercury Involvement in Neuronal Damage and in Neurodegenerative Diseases3.0187Citations (PDF)
169The Isothiocyanate Isolated from Moringa oleifera Shows Potent Anti-Inflammatory Activity in the Treatment of Murine Subacute Parkinson's Disease
Rejuvenation Research, 2017, 20, 50-63
2.566Citations (PDF)
170Mesenchymal stem cell therapy in Parkinson's disease animal models1.742Citations (PDF)
171Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis
Fìtoterapìâ, 2017, 116, 77-84
2.5133Citations (PDF)
172Aberrant expression of β-catenin in CD4+ T cells isolated from primary progressive multiple sclerosis patients
Neuroscience Letters, 2017, 653, 159-162
1.95Citations (PDF)
173The transplantation of mesenchymal stem cells derived from unconventional sources: an innovative approach to multiple sclerosis therapy3.320Citations (PDF)
174The α-cyclodextrin complex of the Moringa isothiocyanate suppresses lipopolysaccharide-induced inflammation in RAW 264.7 macrophage cells through Akt and p38 inhibition
Inflammation Research, 2017, 66, 487-503
4.837Citations (PDF)
175Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells
Journal of Cellular Biochemistry, 2017, 118, 1531-1546
3.033Citations (PDF)
176The combined strategy of mesenchymal stem cells and tissue-engineered scaffolds for spinal cord injury regeneration2.037Citations (PDF)
177Prolonged Expansion Induces Spontaneous Neural Progenitor Differentiation from Human Gingiva-Derived Mesenchymal Stem Cells
Cellular Reprogramming, 2017, 19, 389-401
1.215Citations (PDF)
178Anti‐inflammatory effects of hypoxia‐preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL‐37
FASEB Journal, 2017, 31, 5592-5608
0.677Citations (PDF)
179Triggering of inflammasome by impaired autophagy in response to acute experimental Parkinson’s disease
NeuroReport, 2017, 28, 996-1007
1.538Citations (PDF)
180Topical moringin cream relieves neuropathic pain by suppression of inflammatory pathway and voltage-gated ion channels in murine model of multiple sclerosis
Molecular Pain, 2017, 13,
2.431Citations (PDF)
181Successful ceftazidime-avibactam treatment of MDR-KPC-positive Klebsiella pneumoniae infection in a patient with traumatic brain injury
Medicine (United States), 2017, 96, e7664
1.220Citations (PDF)
182Human periodontal ligament stem cells secretome from multiple sclerosis patients suppresses NALP3 inflammasome activation in experimental autoimmune encephalomyelitis2.275Citations (PDF)
183Conditioned medium from human gingival mesenchymal stem cells protects motor-neuron-like NSC-34 cells against scratch-injury-induced cell death2.249Citations (PDF)
184Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation2.285Citations (PDF)
185Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked With Amyotrophic Lateral Sclerosis3.051Citations (PDF)
186Lack of the Nlrp3 Inflammasome Improves Mice Recovery Following Traumatic Brain Injury3.8118Citations (PDF)
187Mechanism of Action for rTMS: A Working Hypothesis Based on Animal Studies2.848Citations (PDF)
188Role of Vitamin E in the Treatment of Alzheimer’s Disease: Evidence from Animal Models4.4144Citations (PDF)
189Comparison of efficacy and safety of oral agents for the treatment of relapsing–remitting multiple sclerosis
Drug Design, Development and Therapy, 2017, Volume 11, 2193-2207
6.939Citations (PDF)
190Cannabidiol Modulates the Expression of Alzheimer’s Disease-Related Genes in Mesenchymal Stem Cells4.490Citations (PDF)
191Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis3.481Citations (PDF)
192NLRP3 Inflammasome Activation in a Transgenic Amyotrophic Lateral Sclerosis Model
Inflammation, 2017, 41, 93-103
4.069Citations (PDF)
193The Italian Pharmacovigilance Program: An Observational Study of Adverse Effects of Natalizumab in Multiple Sclerosis Therapy
Medical Science Monitor, 2017, 23, 4230-4240
1.27Citations (PDF)
194Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview
Molecules, 2016, 21, 518
4.294Citations (PDF)
195Cannabidiol Modulates the Immunophenotype and Inhibits the Activation of the Inflammasome in Human Gingival Mesenchymal Stem Cells2.876Citations (PDF)
196The role of the Wnt canonical signaling in neurodegenerative diseases
Life Sciences, 2016, 158, 78-88
4.5152Citations (PDF)
197The secretome of periodontal ligament stem cells from MS patients protects against EAE3.4111Citations (PDF)
198Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages
Fìtoterapìâ, 2016, 112, 104-115
2.5111Citations (PDF)
199Conditioned medium of periodontal ligament mesenchymal stem cells exert anti-inflammatory effects in lipopolysaccharide-activated mouse motoneurons
Experimental Cell Research, 2016, 349, 152-161
3.161Citations (PDF)
200Is the Wnt/β-catenin pathway involved in the anti-inflammatory activity of glucocorticoids in spinal cord injury?
NeuroReport, 2016, 27, 1086-1094
1.512Citations (PDF)
201Alternative source of stem cells derived from human periodontal ligament: a new treatment for experimental autoimmune encephalomyelitis6.6155Citations (PDF)
202Anticancer activity of glucomoringin isothiocyanate in human malignant astrocytoma cells
Fìtoterapìâ, 2016, 110, 1-7
2.580Citations (PDF)
203Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis?5.326Citations (PDF)
204Lack of glucocorticoid-induced leucine zipper (GILZ) deregulates B-cell survival and results in B-cell lymphocytosis in mice
Blood, 2015, 126, 1790-1801
4.862Citations (PDF)
205Tuscan black kale sprout extract bioactivated with myrosinase: a novel natural product for neuroprotection by inflammatory and oxidative response during cerebral ischemia/reperfusion injury in rat3.919Citations (PDF)
206A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis1.952Citations (PDF)
207Use of Mometasone furoate in prolonged treatment of experimental spinal cord injury in mice: A comparative study of three different glucocorticoids
Pharmacological Research, 2015, 99, 316-328
9.111Citations (PDF)
208Neuroprotective effects of a polyphenolic white grape juice extract in a mouse model of experimental autoimmune encephalomyelitis
Fìtoterapìâ, 2015, 103, 171-186
2.531Citations (PDF)
209An overview on neuroprotective effects of isothiocyanates for the treatment of neurodegenerative diseases
Fìtoterapìâ, 2015, 106, 12-21
2.5116Citations (PDF)
210Fingolimod-Associated Peripheral Vascular Adverse Effects
Mayo Clinic Proceedings, 2015, 90, 1424-1427
3.711Citations (PDF)
2114(α-l-Rhamnosyloxy)-benzyl isothiocyanate, a bioactive phytochemical that attenuates secondary damage in an experimental model of spinal cord injury2.660Citations (PDF)
212Novel Gram-Scale Production of Enantiopure R-Sulforaphane from Tuscan Black Kale Seeds
Molecules, 2014, 19, 6975-6986
4.233Citations (PDF)
213Use of Natural Compounds in the Management of Diabetic Peripheral Neuropathy
Molecules, 2014, 19, 2877-2895
4.233Citations (PDF)
214Antiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitis
Fìtoterapìâ, 2014, 95, 160-174
2.599Citations (PDF)
215Glucocorticoid‐Induced Leucine Zipper (GILZ) Controls Inflammation and Tissue Damage after Spinal Cord Injury5.016Citations (PDF)
216Are natural killer cells involved in multiple sclerosis etiology? Evidences from NKp46/NCR1 receptor modulation in an observational study2.17Citations (PDF)
217Heavy Metals and Neurodegenerative Diseases: An Observational Study3.097Citations (PDF)
218Transcriptional regulation of kinases downstream of the T cell receptor: another immunomodulatory mechanism of glucocorticoids2.525Citations (PDF)
219(RS)-glucoraphanin purified from Tuscan black kale and bioactivated with myrosinase enzyme protects against cerebral ischemia/reperfusion injury in rats
Fìtoterapìâ, 2014, 99, 166-177
2.516Citations (PDF)
220Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
Molecules, 2014, 19, 18781-18816
4.279Citations (PDF)
221Beneficial effects of (RS)-glucoraphanin on the tight junction dysfunction in a mouse model of restraint stress
Life Sciences, 2013, 93, 288-305
4.512Citations (PDF)
222RS-Glucoraphanin bioactivated with myrosinase treatment counteracts proinflammatory cascade and apoptosis associated to spinal cord injury in an experimental mouse model2.119Citations (PDF)
223Anti-inflammatory and anti-apoptotic effects of (R)-glucoraphanin bioactivated with myrosinase in murine sub-acute and acute MPTP-induced Parkinson’s disease2.631Citations (PDF)
224Protective Role of (RS)-glucoraphanin Bioactivated with Myrosinase in an Experimental Model of Multiple Sclerosis5.040Citations (PDF)
225Antibacterial Activity of Glucomoringin Bioactivated with Myrosinase against Two Important Pathogens Affecting the Health of Long-Term Patients in Hospitals
Molecules, 2013, 18, 14340-14348
4.269Citations (PDF)
226Effect of Fasudil, a Selective Inhibitor of Rho Kinase Activity, in the Secondary Injury Associated with the Experimental Model of Spinal Cord Trauma3.342Citations (PDF)
227Effects of palmitoylethanolamide on intestinal injury and inflammation caused by ischemia-reperfusion in mice
Journal of Leukocyte Biology, 2012, 91, 911-920
2.951Citations (PDF)
228Recombinant Human Activated Protein C (Xigris) Attenuates Murine Cerulein-Induced Acute Pancreatitis Via Regulation of Nuclear Factor κB and Apoptotic Pathways
Pancreas, 2012, 41, 619-628
0.910Citations (PDF)
229Effects of Mitogen-Activated Protein Kinase Signaling Pathway Inhibition on the Development of Cerulein-Induced Acute Pancreatitis in Mice
Pancreas, 2012, 41, 560-570
0.924Citations (PDF)
230The NAMPT inhibitor FK866 reverts the damage in spinal cord injury9.063Citations (PDF)
231Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α9.057Citations (PDF)
232Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
PLoS ONE, 2012, 7, e41880
2.3158Citations (PDF)
233Protective effect of apocynin, a NADPH-oxidase inhibitor, against contrast-induced nephropathy in the diabetic rats: A comparison with n-acetylcysteine4.342Citations (PDF)
234The effects of a polyphenol present in olive oil, oleuropein aglycone, in an experimental model of spinal cord injury in mice
Biochemical Pharmacology, 2012, 83, 1413-1426
5.171Citations (PDF)
235Peroxisome proliferator-activated receptor β/δ agonist GW0742 ameliorates cerulein- and taurocholate-induced acute pancreatitis in mice
Surgery, 2012, 152, 90-106
1.819Citations (PDF)
236Olprinone, a specific phosphodiesterase (PDE)-III inhibitor, reduces the development of multiple organ dysfunction syndrome in mice
Pharmacological Research, 2011, 64, 68-79
9.112Citations (PDF)
237Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury
Brain, Behavior, and Immunity, 2011, 25, 1099-1112
4.5100Citations (PDF)
238Natural almond skin reduced oxidative stress and inflammation in an experimental model of inflammatory bowel disease4.257Citations (PDF)
239Neuroprotective effects of olprinone after cerebral ischemia/reperfusion injury in rats
Neuroscience Letters, 2011, 503, 93-99
1.912Citations (PDF)
240Effects of verbascoside, biotechnologically purified by Syringa vulgaris plant cell cultures, in a rodent model of periodontitis2.930Citations (PDF)
241GITR Gene Deletion and GITR-Fc Soluble Protein Administration Inhibit Multiple Organ Failure Induced by Zymosan
Shock, 2011, 36, 263-271
2.414Citations (PDF)
242Evidence for the role of PI3-kinase-AKT-eNOS signalling pathway in secondary inflammatory process after spinal cord compression injury in mice3.519Citations (PDF)
243PPARα mediates the anti‐inflammatory effect of simvastatin in an experimental model of zymosan‐induced multiple organ failure6.328Citations (PDF)
244Melatonin’s stimulatory effect on adult hippocampal neurogenesis in mice persists after ovariectomy
Journal of Pineal Research, 2011, 51, 353-360
6.930Citations (PDF)
245Hypericum perforatum treatment: effect on behaviour and neurogenesis in a chronic stress model in mice3.950Citations (PDF)
246Neuroprotective effects of almond skins in experimental spinal cord injury
Clinical Nutrition, 2011, 30, 221-233
5.325Citations (PDF)
247The effects of oleuropein aglycone, an olive oil compound, in a mouse model of carrageenan-induced pleurisy
Clinical Nutrition, 2011, 30, 533-540
5.391Citations (PDF)
248Olprinone, a PDE3 inhibitor, modulates the inflammation associated with myocardial ischemia–reperfusion injury in rats4.324Citations (PDF)
249Glutamine treatment attenuates the development of organ injury induced by zymosan administration in mice4.312Citations (PDF)
250CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammation4.350Citations (PDF)
251Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation
Biochemical Pharmacology, 2011, 81, 636-648
5.180Citations (PDF)
252Administration of carnosine in the treatment of acute spinal cord injury
Biochemical Pharmacology, 2011, 82, 1478-1489
5.158Citations (PDF)
253Modulation of NADPH oxidase activation in cerebral ischemia/reperfusion injury in rats
Brain Research, 2011, 1372, 92-102
2.557Citations (PDF)
254Hyperbaric oxygen therapy reduces the toll-like receptor signaling pathway in multiple organ failures
Intensive Care Medicine, 2011, 37, 1110-1119
5.233Citations (PDF)
255Glutamine contributes to ameliorate inflammation after renal ischemia/reperfusion injury in rats2.622Citations (PDF)
256MEK inhibition suppresses the development of lung fibrosis in the bleomycin model2.648Citations (PDF)
257Selective adenosine A2Areceptor agonists and antagonists protect against spinal cord injury through peripheral and central effects9.059Citations (PDF)
258Adrenomedullin in inflammatory process associated with experimental pulmonary fibrosis4.228Citations (PDF)
259Oleuropein Aglycone, an Olive Oil Compound, Ameliorates Development of Arthritis Caused by Injection of Collagen Type II in Mice3.383Citations (PDF)
260Effect of Apocynin, an inhibitor of NADPH oxidase, in the inflammatory process induced by an experimental model of spinal cord injury
Free Radical Research, 2011, 45, 221-236
2.646Citations (PDF)
261In vitromodel for IgE mediated food allergy1.728Citations (PDF)
262Apocynin, a Plant-Derived Drug, Might Be Useful in the Treatment of Myocardial Ischemia Reperfusion Injury in Rat Hearts0.65Citations (PDF)
263Effect of NADPH-oxidase inhibitors in the experimental model of zymosan-induced shock in mice
Free Radical Research, 2011, 45, 820-834
2.611Citations (PDF)
264CGS 21680, an Agonist of the Adenosine (A2A) Receptor, Reduces Progression of Murine Type II Collagen-induced Arthritis
Journal of Rheumatology, 2011, 38, 2119-2129
2.373Citations (PDF)
265Glucocorticoid-Induced Leucine Zipper (GILZ) Over-Expression in T Lymphocytes Inhibits Inflammation and Tissue Damage in Spinal Cord Injury
Neurotherapeutics, 2011, 9, 210-225
6.055Citations (PDF)
266PDE 7 Inhibitors: New Potential Drugs for the Therapy of Spinal Cord Injury
PLoS ONE, 2011, 6, e15937
2.365Citations (PDF)
267GW0742, A HIGH-AFFINITY PPAR -β/δ AGONIST, INHIBITS ACUTE LUNG INJURY IN MICE
Shock, 2010, 33, 426-435
2.436Citations (PDF)
268Efficacy of treatment with verbascoside, biotechnologically produced by Syringa vulgaris plant cell cultures in an experimental mice model of spinal cord trauma2.612Citations (PDF)
269Olprinone attenuates the development of ischemia/reperfusion injury of the gut
Intensive Care Medicine, 2010, 36, 1235-1247
5.220Citations (PDF)
270Effects of Liver × receptor agonist treatment on signal transduction pathways in acute lung inflammation4.225Citations (PDF)
271Effects of Hypericum Perforatum, in a rodent model of periodontitis3.940Citations (PDF)
272Glutamine treatment attenuates the development of ischaemia/reperfusion injury of the gut4.352Citations (PDF)
273Role of PPAR-δ in the development of zymosan-induced multiple organ failure: an experiment mice study4.022Citations (PDF)
274Liver X receptor agonist treatment regulates inflammatory response after spinal cord trauma
Journal of Neurochemistry, 2010, 112, 611-624
3.835Citations (PDF)
275Melatonin treatment mimics the antidepressant action in chronic corticosterone‐treated mice
Journal of Pineal Research, 2010, 49, 123-129
6.977Citations (PDF)
276Melatonin reduces hyperalgesia associated with inflammation
Journal of Pineal Research, 2010, 49, 321-331
6.974Citations (PDF)
277Estrogen Receptor-α as a Drug Target Candidate for Preventing Lung Inflammation
Endocrinology, 2010, 151, 174-184
2.572Citations (PDF)
278Liver X receptor agonist treatment reduced splanchnic ischemia and reperfusion injury
Journal of Leukocyte Biology, 2010, 87, 309-321
2.923Citations (PDF)
279Protective effects of apocynin, an inhibitor of NADPH oxidase activity, in splanchnic artery occlusion and reperfusion
Journal of Leukocyte Biology, 2010, 88, 993-1003
2.934Citations (PDF)
280Ethyl Pyruvate Therapy Attenuates Experimental Severe Arthritis Caused by Type II Collagen (CII) in the Mouse (CIA)2.26Citations (PDF)
281Modulation of inflammatory response after spinal cord trauma with deferoxamine, an iron chelator
Free Radical Research, 2010, 44, 694-709
2.625Citations (PDF)
282PD98059, a specific MAP kinase inhibitor, attenuates multiple organ dysfunction syndrome/failure (MODS) induced by zymosan in mice
Pharmacological Research, 2010, 61, 175-187
9.146Citations (PDF)
2833,5-Dicaffeoyl-4-malonylquinic acid reduced oxidative stress and inflammation in a experimental model of inflammatory bowel disease
Free Radical Research, 2010, 44, 74-89
2.616Citations (PDF)
284ADENOSINE A2A RECEPTOR-SELECTIVE STIMULATION REDUCES SIGNALING PATHWAYS INVOLVED IN THE DEVELOPMENT OF INTESTINE ISCHEMIA AND REPERFUSION INJURY
Shock, 2010, 33, 541-551
2.419Citations (PDF)
285Olprinone Attenuates the Acute Inflammatory Response and Apoptosis after Spinal Cord Trauma in Mice
PLoS ONE, 2010, 5, e12170
2.316Citations (PDF)
286Peroxisome Proliferator-Activated Receptor-α Contributes to the Resolution of Inflammation after Renal Ischemia/Reperfusion Injury3.340Citations (PDF)
287Myrtucommulone from Myrtus communis Exhibits Potent Anti-Inflammatory Effectiveness in Vivo3.393Citations (PDF)
288PPAR-α Contributes to the Anti-Inflammatory Activity of 17β-Estradiol3.328Citations (PDF)
289Dexamethasone Ameliorates Renal Ischemia-Reperfusion Injury0.4122Citations (PDF)
290Role of peroxisome proliferator-activated receptor-α in ileum tight junction alteration in mouse model of restraint stress3.216Citations (PDF)
291Teupolioside, a phenylpropanoid glycosides of Ajuga reptans, biotechnologically produced by IRBN22 plant cell line, exerts beneficial effects on a rodent model of colitis
Biochemical Pharmacology, 2009, 77, 845-857
5.124Citations (PDF)
292Pure MnTBAP selectively scavenges peroxynitrite over superoxide: Comparison of pure and commercial MnTBAP samples to MnTE-2-PyP in two models of oxidative stress injury, an SOD-specific Escherichia coli model and carrageenan-induced pleurisy3.7132Citations (PDF)
293Erythropoietin suppresses peritoneal fibrosis in rat experimental model4.315Citations (PDF)
294Effects of verbascoside biotechnologically produced by Syringa vulgaris plant cell cultures in a rodent model of colitis2.642Citations (PDF)
295Treatment with green tea extract attenuates secondary inflammatory response in an experimental model of spinal cord trauma2.634Citations (PDF)
296Protective effect of melatonin against the inflammatory response elicited by crude venom from isolated nematocysts of Pelagia noctiluca (Cnidaria, Scyphozoa)6.931Citations (PDF)
297Absence of endogenous interleukin‐10 enhances secondary inflammatory process after spinal cord compression injury in mice
Journal of Neurochemistry, 2009, 108, 1360-1372
3.877Citations (PDF)
298Protective Effects of a Coumarin Derivative in Diabetic Rats
2009, 50, 3846
63Citations (PDF)
299PPAR-α modulate the anti-inflammatory effect of glucocorticoids in the secondary damage in experimental spinal cord trauma
Pharmacological Research, 2009, 59, 338-350
9.142Citations (PDF)
300Ibuprofen–arginine generates nitric oxide and has enhanced anti-inflammatory effects
Pharmacological Research, 2009, 60, 221-228
9.137Citations (PDF)
301Glucocorticoid-Induced Leucine Zipper Is Protective in Th1-Mediated Models of Colitis
Gastroenterology, 2009, 136, 530-541
0.9127Citations (PDF)
302The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury
Brain, 2009, 132, 2206-2218
8.4121Citations (PDF)
303Effects of a metalloporphyrinic peroxynitrite decomposition catalyst, ww-85, in a mouse model of spinal cord injury
Free Radical Research, 2009, 43, 631-645
2.629Citations (PDF)
304BENEFICIAL EFFECTS OF ETHYL PYRUVATE IN A MOUSE MODEL OF SPINAL CORD INJURY
Shock, 2009, 32, 217-227
2.426Citations (PDF)
305Ethyl pyruvate reduces the development of zymosan-induced generalized inflammation in mice
Critical Care Medicine, 2009, 37, 270-282
0.523Citations (PDF)
306Green Tea Polyphenols Ameliorate Pancreatic Injury in Cerulein-Induced Murine Acute Pancreatitis
Pancreas, 2009, 38, 954-967
0.929Citations (PDF)
307GLYCYRRHIZIN REDUCES SECONDARY INFLAMMATORY PROCESS AFTER SPINAL CORD COMPRESSION INJURY IN MICE
Shock, 2009, 31, 367-375
2.441Citations (PDF)
308FUMONISIN B1 REDUCES THE DEVELOPMENT OF MULTIPLE ORGAN FAILURE INDUCED BY ZYMOSAN IN MICE
Shock, 2009, 31, 170-177
2.412Citations (PDF)
309INHIBITION OF CERAMIDE BIOSYNTHESIS AMELIORATES PATHOLOGICAL CONSEQUENCES OF SPINAL CORD INJURY
Shock, 2009, 31, 635-645
2.424Citations (PDF)
310THE SELECTIVE ADENOSINE A2A RECEPTOR AGONIST CGS 21680 REDUCES JNK MAPK ACTIVATION IN OLIGODENDROCYTES IN INJURED SPINAL CORD
Shock, 2009, 32, 578-585
2.443Citations (PDF)
311ANTI-APOPTOTIC AND ANTI-INFLAMMATORY EFFECTS OF HYDROGEN SULFIDE IN A RAT MODEL OF REGIONAL MYOCARDIAL I/R
Shock, 2009, 31, 267-274
2.4240Citations (PDF)
312THALIDOMIDE SUPPRESSES SCLEROSING ENCAPSULATING PERITONITIS IN A RAT EXPERIMENTAL MODEL
Shock, 2009, 32, 332-339
2.421Citations (PDF)
313Effect of PD98059, a Selective MAPK3/MAPK1 Inhibitor, on Acute Lung Injury in Mice2.250Citations (PDF)
314PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-α MODULATES THE ANTI-INFLAMMATORY EFFECT OF GLUCOCORTICOIDS IN A MODEL OF INFLAMMATORY BOWEL DISEASE IN MICE
Shock, 2009, 31, 308-316
2.448Citations (PDF)
315Matrix metalloproteinase‐9 and metalloproteinase‐2 activity and expression is reduced by melatonin during experimental colitis
Journal of Pineal Research, 2008, 45, 166-173
6.958Citations (PDF)
316Effect of tumour necrosis factor-α receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept3.333Citations (PDF)
317Protective effect of Arbutus unedo aqueous extract in carrageenan-induced lung inflammation in mice
Pharmacological Research, 2008, 57, 110-124
9.175Citations (PDF)
318Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice
Pharmacological Research, 2008, 58, 22-31
9.1108Citations (PDF)
319Treatment of life-threatening type I refractory coeliac disease with long-term infliximab2.562Citations (PDF)
320Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome
Cytokine, 2008, 41, 136-143
3.514Citations (PDF)
321Effects of Palmitoylethanolamide on Signaling Pathways Implicated in the Development of Spinal Cord Injury3.3107Citations (PDF)
322Dynamics of enterocyte tight junctions: effect of experimental colitis and two different anti-TNF strategies3.261Citations (PDF)
323Role of TNF-α in ileum tight junction alteration in mouse model of restraint stress3.258Citations (PDF)
324Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Related (GITR)-Fc Fusion Protein Inhibits GITR Triggering and Protects from the Inflammatory Response after Spinal Cord Injury
Molecular Pharmacology, 2008, 73, 1610-1621
2.632Citations (PDF)
325Cyclooxygenases 1 and 2 contribute to peroxynitrite‐mediated inflammatory pain hypersensitivity
FASEB Journal, 2008, 22, 3154-3164
0.684Citations (PDF)
326Anti-Inflammatory and Anti-Apoptotic Effects of Fumonisin B1, an Inhibitor of Ceramide Synthase, in a Rodent Model of Splanchnic Ischemia and Reperfusion Injury3.333Citations (PDF)
327Evidence for the Role of Mitogen-Activated Protein Kinase Signaling Pathways in the Development of Spinal Cord Injury3.347Citations (PDF)
328Peroxisome Proliferator-Activated Receptor-α Contributes to the Anti-Inflammatory Activity of Glucocorticoids
Molecular Pharmacology, 2008, 73, 323-337
2.659Citations (PDF)
329Sphingosylphosphorylcholine reduces the organ injury/dysfunction and inflammation caused by endotoxemia in the rat
Critical Care Medicine, 2008, 36, 550-559
0.520Citations (PDF)
330TNF-α BLOCKAGE IN A MOUSE MODEL OF SCI
Shock, 2008, 29, 32-41
2.497Citations (PDF)
331Infliximab and Etanercept Are Equally Effective in Reducing Enterocyte APOPTOSIS in Experimental Colitis2.752Citations (PDF)
332Protective effects of glycyrrhizin in a gut hypoxia (ischemia)-reoxygenation (reperfusion) model
Intensive Care Medicine, 2008, 35, 687-697
5.232Citations (PDF)
333EFFECTS OF THALIDOMIDE IN A MOUSE MODEL OF CERULEIN-INDUCED ACUTE PANCREATITIS
Shock, 2008, 29, 89-97
2.434Citations (PDF)
334EFFECT OF 17β-ESTRADIOL ON SIGNAL TRANSDUCTION PATHWAYS AND SECONDARY DAMAGE IN EXPERIMENTAL SPINAL CORD TRAUMA
Shock, 2008, 29, 362-371
2.462Citations (PDF)
335ETANERCEPT REDUCES ACUTE TISSUE INJURY AND MORTALITY ASSOCIATED TO ZYMOSAN-INDUCED MULTIPLE ORGAN DYSFUNCTION SYNDROME
Shock, 2008, 29, 560-571
2.47Citations (PDF)
336EFFECT OF CYCLOPENTANONE PROSTAGLANDIN 15-DEOXY-Δ12,14PGJ2 ON EARLY FUNCTIONAL RECOVERY FROM EXPERIMENTAL SPINAL CORD INJURY
Shock, 2008, 30, 142-152
2.428Citations (PDF)
337EFFECT OF THALIDOMIDE ON SIGNAL TRANSDUCTION PATHWAYS AND SECONDARY DAMAGE IN EXPERIMENTAL SPINAL CORD TRAUMA
Shock, 2008, 30, 231-240
2.414Citations (PDF)
338Genetic and pharmacological inhibition of GITR‐GITRL interaction reduces chronic lung injury induced by bleomycin instillation
FASEB Journal, 2007, 21, 117-129
0.639Citations (PDF)
339ETANERCEPT ATTENUATES THE DEVELOPMENT OF CERULEIN-INDUCED ACUTE PANCREATITIS IN MICE
Shock, 2007, 27, 542-551
2.439Citations (PDF)
340GLYCOGEN SYNTHASE KINASE 3β INHIBITION REDUCES THE DEVELOPMENT OF NONSEPTIC SHOCK INDUCED BY ZYMOSAN IN MICE
Shock, 2007, 27, 97-107
2.432Citations (PDF)
341Splanchnic ischemia and reperfusion injury is reduced by genetic or pharmacological inhibition of TNF-α
Journal of Leukocyte Biology, 2007, 81, 1032-1043
2.930Citations (PDF)
342Effects of glycogen synthase kinase-3[beta] inhibition on the development of cerulein-induced acute pancreatitis in mice *
Critical Care Medicine, 2007, 35, 2811-2821
0.50Citations (PDF)
343BENEFICIAL EFFECTS OF A PLANT HISTAMINASE IN A RAT MODEL OF SPLANCHNIC ARTERY OCCLUSION AND REPERFUSION
Shock, 2007, 27, 409-415
2.421Citations (PDF)
344N-BENZYLOXYCARBONYL-VAL-ALA-ASP-FLUOROMETHYLKETONE REDUCES SEVERITY OF EXPERIMENTAL SPINAL CORD INJURY
Shock, 2007, 27, 258-265
2.48Citations (PDF)
345Effects of glycogen synthase kinase-3β inhibition on the development of cerulein-induced acute pancreatitis in mice*
Critical Care Medicine, 2007, 35, 2811-2821
0.519Citations (PDF)
346ABSENCE OF FUNCTIONAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-α ENHANCED ILEUM PERMEABILITY DURING EXPERIMENTAL COLITIS
Shock, 2007, 28, 192-201
2.438Citations (PDF)
347ROLE OF TUMOR NECROSIS FACTOR-α IN ACUTE PANCREATITIS
Shock, 2007, 28, 130-140
2.4133Citations (PDF)
348Inhibition of tyrosine kinase-mediated cellular signalling by Tyrphostins AG126 and AG556 modulates secondary damage in experimental spinal cord trauma
Neuropharmacology, 2007, 52, 1454-1471
4.310Citations (PDF)
349Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma
Neuroscience, 2007, 150, 168-181
2.340Citations (PDF)
350Role of endogenous glutathione in the secondary damage in experimental spinal cord injury in mice
Neuroscience Letters, 2007, 423, 41-46
1.926Citations (PDF)
351Role of TNF-α in lung tight junction alteration in mouse model of acute lung inflammation4.2133Citations (PDF)
352Lymphocytic Vasculitis Associated with Icodextrin3.43Citations (PDF)
353Effects of combination of melatonin and dexamethasone on secondary injury in an experimental mice model of spinal cord trauma
Journal of Pineal Research, 2007, 43, 140-153
6.951Citations (PDF)
354In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: Modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models
Clinical Immunology, 2007, 123, 311-323
2.662Citations (PDF)
355Role of poly(ADP-ribose) glycohydrolase in the development of inflammatory bowel disease in mice3.742Citations (PDF)
356Beneficial effects of FeTSPP, a peroxynitrite decomposition catalyst, in a mouse model of spinal cord injury3.737Citations (PDF)
357The role of cycloxygenase-2 in the rodent kidney following ischaemia/reperfusion injury in vivo4.342Citations (PDF)
358Modulation of Acute and Chronic Inflammation of the Lung by GITR and its Ligand4.018Citations (PDF)
359Inhibition of inducible nitric oxide synthase in vitro and in vivo by a water-soluble extract of Wendita calysina leaves2.69Citations (PDF)
360Glycogen synthase kinase-3β inhibition attenuates the development of ischaemia/reperfusion injury of the gut
Intensive Care Medicine, 2007, 33, 880-893
5.256Citations (PDF)
361Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury4.244Citations (PDF)
362Copper Activates the NF-κB PathwayIn Vivo6.351Citations (PDF)
363Pharmacological Inhibition of Leukotrienes in an Animal Model of Bleomycin-Induced Lung Fibrosis: Role of the Cysteinyl and B4 Leukotrienes6.10Citations (PDF)
364Increased oxidative-related mechanisms in the spinal cord injury in old rats
Neuroscience Letters, 2006, 393, 141-146
1.938Citations (PDF)
365Increased GILZ expression in transgenic mice up-regulates Th-2 lymphokines
Blood, 2006, 107, 1039-1047
4.891Citations (PDF)
3665-LIPOXYGENASE MODULATES THE ALTERATION OF PARACELLULAR BARRIER FUNCTION IN MICE ILEUM DURING EXPERIMENTAL COLITIS
Shock, 2006, 25, 377-383
2.415Citations (PDF)
367NEUROPROTECTION AND ENHANCED RECOVERY WITH HYPERICUM PERFORATUM EXTRACT AFTER EXPERIMENTAL SPINAL CORD INJURY IN MICE
Shock, 2006, 25, 608-617
2.423Citations (PDF)
368HYPERICUM PERFORATUM ATTENUATES THE DEVELOPMENT OF CERULEIN-INDUCED ACUTE PANCREATITIS IN MICE
Shock, 2006, 25, 161-167
2.444Citations (PDF)
369GLYCOGEN SYNTHASE KINASE-3β INHIBITORS PROTECT AGAINST THE ORGAN INJURY AND DYSFUNCTION CAUSED BY HEMORRHAGE AND RESUSCITATION
Shock, 2006, 25, 485-491
2.456Citations (PDF)
370Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice*
Critical Care Medicine, 2006, 34, 1168-1177
0.566Citations (PDF)
371ROLE OF ENDOGENOUS PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-α (PPAR-α) LIGANDS IN THE DEVELOPMENT OF GUT ISCHEMIA AND REPERFUSION IN MICE
Shock, 2006, 25, 17-22
2.48Citations (PDF)
372THALIDOMIDE TREATMENT REDUCES THE ALTERATION OF PARACELLULAR BARRIER FUNCTION IN MICE ILEUM DURING EXPERIMENTAL COLITIS
Shock, 2006, 25, 515-521
2.411Citations (PDF)
373Melatonin modulates signal transduction pathways and apoptosis in experimental colitis
Journal of Pineal Research, 2006, 41, 363-373
6.974Citations (PDF)
374Protective effects of relaxin in ischemia/reperfusion-induced intestinal injury due to splanchnic artery occlusion
British Journal of Pharmacology, 2006, 148, 1124-1132
6.346Citations (PDF)
375Tyrphostin AG 126 reduces intestinal ischemia-reperfusion injury in the rat2.68Citations (PDF)
376Cloricromene, a coumarine derivative, reduced the development of periodontitis in rats2.64Citations (PDF)
377Hypericum perforatum attenuates the development of carrageenan-induced lung injury in mice3.741Citations (PDF)
378A novel adamantane derivative attenuates retinal ischemia–reperfusion damage in the rat retina through σ1 receptors4.320Citations (PDF)
379Pyrrolidine dithiocarbamate reduced experimental periodontitis4.312Citations (PDF)
380Effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, in a mouse model of acute pancreatitis induced by cerulein4.335Citations (PDF)
381GREEN TEA POLYPHENOL EXTRACT ATTENUATES ZYMOSAN-INDUCED NON-SEPTIC SHOCK IN MICE
Shock, 2006, 26, 402-409
2.4106Citations (PDF)
382CYTOKINE-TRIGGERED DECREASES IN LEVELS OF PHOSPHORYLATED EUKARYOTIC INITIATION FACTOR 4G IN SKELETAL MUSCLE DURING SEPSIS
Shock, 2006, 26, 631-636
2.441Citations (PDF)
383The role of the peroxisome proliferator-activated receptor-α (PPAR-α) in the regulation of acute inflammation
Journal of Leukocyte Biology, 2006, 79, 999-1010
2.994Citations (PDF)
384Poly(ADP-Ribose) Glycohydrolase Activity Mediates Post-Traumatic Inflammatory Reaction after Experimental Spinal Cord Trauma3.332Citations (PDF)
385Immunomodulatory Effects of Etanercept in an Experimental Model of Spinal Cord Injury3.3138Citations (PDF)
386A Role for Nitric Oxide-Mediated Peroxynitrite Formation in a Model of Endotoxin-Induced Shock3.392Citations (PDF)
387Glycogen Synthase Kinase-3β Inhibition Reduces Secondary Damage in Experimental Spinal Cord Trauma3.366Citations (PDF)
388INHIBITORS OF NADPH OXIDASE REDUCE THE ORGAN INJURY IN HEMORRHAGIC SHOCK
Shock, 2005, 23, 107-114
2.466Citations (PDF)
389EFFECTS OF HYPERICUM PERFORATUM EXTRACT IN A RAT MODEL OF ISCHEMIA AND REPERFUSION INJURY
Shock, 2005, 24, 255-263
2.423Citations (PDF)
390ROLE OF ENDOGENOUS AND EXOGENOUS LIGANDS FOR THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α IN THE DEVELOPMENT OF BLEOMYCIN-INDUCED LUNG INJURY
Shock, 2005, 24, 547-555
2.439Citations (PDF)
391Increased carrageenan‐induced acute lung inflammation in old rats
Immunology, 2005, 115, 253-261
4.739Citations (PDF)
3925-Lipoxygenase modulates colitis through the regulation of adhesion molecule expression and neutrophil migration
Laboratory Investigation, 2005, 85, 808-822
3.255Citations (PDF)
393Attenuation in the evolution of experimental spinal cord trauma by treatment with melatonin
Journal of Pineal Research, 2005, 38, 198-208
6.9100Citations (PDF)
394Beneficial effects of GW274150 treatment on the development of experimental colitis induced by dinitrobenzene sulfonic acid4.311Citations (PDF)
395Reduced development of experimental periodontitis by treatment with M40403, a superoxide dismutase mimetic4.319Citations (PDF)
396Treatment with PARP-1 inhibitors, GPI 15427 or GPI 16539, ameliorates intestinal damage in rat models of colitis and shock4.326Citations (PDF)
397Inhibitors of calpain activation (PD150606 and E-64) and renal ischemia-reperfusion injury
Biochemical Pharmacology, 2005, 69, 1121-1131
5.146Citations (PDF)
398Inhibition of tyrosine-kinase–mediated cellular signaling by tyrphostins AG 126 and AG556 modulates murine experimental acute pancreatitis
Surgery, 2005, 138, 913-923
1.822Citations (PDF)
399Involvement of 5-lipoxygenase in spinal cord injury
Journal of Neuroimmunology, 2005, 166, 55-64
2.326Citations (PDF)
400Erythropoietin reduces the degree of arthritis caused by type II collagen in the mouse
Arthritis and Rheumatism, 2005, 52, 940-950
6.154Citations (PDF)
401Effects of combination M40403 and dexamethasone therapy on joint disease in a rat model of collagen-induced arthritis
Arthritis and Rheumatism, 2005, 52, 1929-1940
6.164Citations (PDF)
402Synergistic interaction between methotrexate and a superoxide dismutase mimetic: Pharmacologic and potential clinical significance
Arthritis and Rheumatism, 2005, 52, 3755-3760
6.129Citations (PDF)
403Green tea polyphenol extract attenuates ischemia/reperfusion injury of the gut2.634Citations (PDF)
404The cyclopentenone prostaglandin 15-deoxyΔ12,14-prostaglandin J2 attenuates the development of zymosan-induced shock
Intensive Care Medicine, 2005, 31, 693-700
5.211Citations (PDF)
405Inhibitors of Poly(ADP-Ribose) Polymerase Modulate Signal Transduction Pathways and Secondary Damage in Experimental Spinal Cord Trauma3.369Citations (PDF)
406Role of glucocorticoid‐induced TNF receptor family gene (GITR) in collagen‐induced arthritis
FASEB Journal, 2005, 19, 1253-1265
0.696Citations (PDF)
407Endogenous Interleukin-6 Enhances the Renal Injury, Dysfunction, and Inflammation Caused by Ischemia/Reperfusion3.3168Citations (PDF)
408Inhibitors of Poly(ADP-Ribose) Polymerase Modulate Signal Transduction Pathways and the Development of Bleomycin-Induced Lung Injury3.340Citations (PDF)
409PARG activity mediates intestinal injury induced by splanchnic artery occlusion and reperfusion
FASEB Journal, 2005, 19, 558-566
0.652Citations (PDF)
410Role of endogenous ligands for the peroxisome proliferators activated receptors alpha in the secondary damage in experimental spinal cord trauma
Experimental Neurology, 2005, 194, 267-278
4.049Citations (PDF)
411Green tea polyphenol extract attenuates lung injury in experimental model of carrageenan-induced pleurisy in mice4.251Citations (PDF)
412Green tea polyphenol extract attenuates colon injury induced by experimental colitis
Free Radical Research, 2005, 39, 1017-1025
2.682Citations (PDF)
413Erythropoietin Reduces the Development of Experimental Inflammatory Bowel Disease3.358Citations (PDF)
414WY 14643, A POTENT EXOGENOUS PPAR-?? LIGAND, REDUCES INTESTINAL INJURY ASSOCIATED WITH SPLANCHNIC ARTERY OCCLUSION SHOCK
Shock, 2004, 22, 340-346
2.435Citations (PDF)
415Glucocorticoid-induced TNF receptor family gene (GITR) knockout mice exhibit a resistance to splanchnic artery occlusion (SAO) shock
Journal of Leukocyte Biology, 2004, 76, 933-940
2.936Citations (PDF)
416Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-α) in the development of inflammatory bowel disease in mice
Laboratory Investigation, 2004, 84, 1643-1654
3.293Citations (PDF)
417Calpain I inhibitor ameliorates the indices of disease severity in a murine model of cerulein-induced acute pancreatitis
Intensive Care Medicine, 2004, 30, 1645-1651
5.248Citations (PDF)
4185-Aminoisoquinolinone reduces colon injury by experimental colitis2.620Citations (PDF)
419A protective effect of the synthetic coumarine derivative Cloricromene against DNB-colitis in the rat
Life Sciences, 2004, 74, 2749-2756
4.54Citations (PDF)
420Superoxide: a key player in hypertension
FASEB Journal, 2004, 18, 94-101
0.697Citations (PDF)
421Calpain Inhibitor I Reduces Intestinal Ischemia-Reperfusion Injury in the Rat
Shock, 2004, 21, 38-44
2.422Citations (PDF)
422REDUCTION IN THE DEVELOPMENT OF CERULEIN-INDUCED ACUTE PANCREATITIS BY TREATMENT WITH M40401, A NEW SELECTIVE SUPEROXIDE DISMUTASE MIMETIC
Shock, 2004, 22, 254-261
2.441Citations (PDF)
423Protective effects of M40401, a selective superoxide dismutase mimetic, on zymosan-induced nonseptic shock
Critical Care Medicine, 2004, 32, 157-167
0.514Citations (PDF)
424NF-kB inhibition by pyrrolidine dithiocarbamate attenuates experimental acute pancreatitis
Gastroenterology, 2003, 124, A501-A502
0.93Citations (PDF)
425A time course of inflammation-associated effects on small intestine tight junction (TJ) proteins
Gastroenterology, 2003, 124, A317
0.91Citations (PDF)
426Protective effects of cyanidin-3-O-glucoside from blackberry extract against peroxynitrite-induced endothelial dysfunction and vascular failure
Life Sciences, 2003, 73, 1097-1114
4.5169Citations (PDF)
4275-Lipoxygenase knockout mice exhibit a resistance to pleurisy and lung injury caused by carrageenan
Journal of Leukocyte Biology, 2003, 73, 739-746
2.931Citations (PDF)
428Pyrrolidine Dithiocarbamate Reduces the Severity of Cerulein-Induced Murine Acute Pancreatitis
Shock, 2003, 20, 544-550
2.457Citations (PDF)
429Effects of Cloricromene, a Coumarin Derivative, on Endotoxin-Induced Uveitis in Lewis Rats
2003, 44, 1178
24Citations (PDF)
430The Cyclopentenone Prostaglandin 15-Deoxy-Δ12,14-Prostaglandin J2Attenuates the Development of Acute and Chronic Inflammation
Molecular Pharmacology, 2002, 61, 997-1007
2.6122Citations (PDF)
431ABSENCE OF ENDOGENOUS INTERLEUKIN-6 ENHANCES THE INFLAMMATORY RESPONSE DURING ACUTE PANCREATITIS IN MICE.
Shock, 2002, 17, 19
2.40Citations (PDF)
432Role of Tight Junction Derangement in the Endothelial Dysfunction Elicited by Exogenous and Endogenous Peroxynitrite and Poly(ADP-Ribose) Synthetase
Shock, 2002, 18, 434-439
2.432Citations (PDF)
433THE PPAR-γ LIGAND 15-DEOXYΔ12,14PGJ2 ATTENUATES THE DEVELOPMENT OF INTESTINAL ISCHEMIA/REPERFUSION.
Shock, 2002, 17, 48
2.40Citations (PDF)
434Role of Induced Nitric Oxide in the Initiation of the Inflammatory Response After Postischemic Injury
Shock, 2002, 18, 169-176
2.4111Citations (PDF)
435Beneficial Effects Of GPI 6150, an Inhibitor of Poly(ADP-Ribose) Polymerase in a Rat Model of Splanchnic Artery Occlusion and Reperfusion
Shock, 2002, 17, 222-227
2.435Citations (PDF)
436Inducible Nitric Oxide Synthase-Deficient Mice Exhibit Resistance to the Acute Pancreatitis Induced by Cerulein
Shock, 2002, 17, 416-422
2.472Citations (PDF)
437ABSENCE OF ENDOGENOUS INTERLEUKIN-6 ENHANCES THE INFLAMMATORY RESPONSE DURING ACUTE PANCREATITIS INDUCED BY CERULEIN IN MICE
Cytokine, 2002, 18, 274-285
3.548Citations (PDF)
438Role of IL-10 in Hepatocyte Tight Junction Alteration in Mouse Model of Experimental Colitis
Molecular Medicine, 2002, 8, 353-366
5.650Citations (PDF)
439Effect of zinc supplementation on intestinal permeability in experimental colitis
Translational Research, 2002, 139, 311-315
2.2115Citations (PDF)
440Beneficial effects of GW274150, a novel, potent and selective inhibitor of iNOS activity, in a rodent model of collagen-induced arthritis4.356Citations (PDF)
441Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase, in a rodent model of lung injury
Biochemical Pharmacology, 2002, 63, 293-304
5.172Citations (PDF)
442Protective effects of Celecoxib on lung injury and red blood cells modification induced by carrageenan in the rat
Biochemical Pharmacology, 2002, 63, 785-795
5.153Citations (PDF)
443GPI 6150, a PARP inhibitor, reduces the colon injury caused by dinitrobenzene sulfonic acid in the rat
Biochemical Pharmacology, 2002, 64, 327-337
5.142Citations (PDF)
444The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat
Intensive Care Medicine, 2002, 28, 775-788
5.223Citations (PDF)
445The Cyclopentenone Prostaglandin 15-Deoxy-Δ12,14-Prostaglandin J2Attenuates the Development of Acute and Chronic Inflammation
Molecular Pharmacology, 2002, 61, 997-1007
2.63Citations (PDF)
446Effect of zinc supplementation on trace elements and intestinal metallothionein concentrations in experimental colitis in the rat
Digestive and Liver Disease, 2001, 33, 135-139
2.531Citations (PDF)
447Protective effects ofn‐acetylcysteine on lung injury and red blood cell modification induced by carrageenan in the rat
FASEB Journal, 2001, 15, 1187-1200
0.696Citations (PDF)
448The Protective Role of Endogenous Estrogens in Carrageenan-Induced Lung Injury in the Rat
Molecular Medicine, 2001, 7, 478-487
5.683Citations (PDF)
449BENEFICIAL EFFECTS OF GPI 6150, AN INHIBITOR OF POLY(ADP-RIBOSE) POLYMERASE IN A RAT MODEL OF SPLANCHNIC ARTERY OCCLUSION AND REPERFUSION.
Shock, 2001, 15, 58-59
2.40Citations (PDF)
450INDUCIBLE NITRIC OXIDE SYNTHASE KNOCKOUT MICE EXHIBIT RESISTANCE TO THE MULTIPLE ORGAN FAILURE INDUCED BY ZYMOSAN
Shock, 2001, 16, 51-58
2.454Citations (PDF)
451Melatonin reduces dinitrobenzene sulfonic acid-induced colitis6.9117Citations (PDF)
452Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic
Arthritis and Rheumatism, 2001, 44, 2909-2921
6.193Citations (PDF)
453Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion6.3104Citations (PDF)
454Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M404036.3125Citations (PDF)
455GPI 6150, a poly (ADP-ribose) polymerase inhibitor, exhibits an anti-inflammatory effect in rat models of inflammation4.333Citations (PDF)
456Effect of N-acetylcysteine on gentamicin-mediated nephropathy in rats4.390Citations (PDF)
457Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats4.351Citations (PDF)
458Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis4.363Citations (PDF)
459EFFECTS OF N-ACETYLCYSTEINE, A RADICAL SCAVENGER, ON LUNG INJURY AND RED BLOOD CELLS MODIFICATION INDUCED BY CARRAGEENAN IN THE RAT.
Shock, 2001, 15, 82
2.40Citations (PDF)
460Beneficial effects of tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat
Critical Care Medicine, 2001, 29, 102-111
0.572Citations (PDF)
461Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat
Gut, 2001, 48, 478-488
16.837Citations (PDF)
462Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of collagen-induced arthritis6.167Citations (PDF)
463Protective effects of melatonin in ischemic brain injury
Journal of Pineal Research, 2000, 29, 217-227
6.9130Citations (PDF)
464Beneficial effects of melatonin in a rat model of splanchnic artery occlusion and reperfusion6.984Citations (PDF)
465Beneficial effects of n -acetylcysteine on ischaemic brain injury
British Journal of Pharmacology, 2000, 130, 1219-1226
6.381Citations (PDF)
466The Tyrosine Kinase Inhibitor Tyrphostin AG 126 Reduces the Development of Colitis in the Rat
Laboratory Investigation, 2000, 80, 1439-1453
3.220Citations (PDF)
467Effects of tempol, a membrane-permeable radical scavenger, in a rodent model of carrageenan-induced pleurisy4.359Citations (PDF)
468Tempol, a membrane-permeable radical scavenger, reduces dinitrobenzene sulfonic acid-induced colitis4.348Citations (PDF)
469Role of Free Radicals and Poly(ADP-ribose) Synthetase in Intestinal Tight Junction Permeability
Molecular Medicine, 2000, 6, 766-778
5.650Citations (PDF)
470Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion
FASEB Journal, 2000, 14, 1061-1072
0.699Citations (PDF)
471Inducible Nitric Oxide Synthase—Knockout Mice Exhibit Resistance to Pleurisy and Lung Injury Caused by Carrageenan8.9101Citations (PDF)
472Effects of n-acetylcysteine in a rat model of ischemia and reperfusion injury
Cardiovascular Research, 2000, 47, 537-548
5.5128Citations (PDF)
47317β-Estradiol Antiinflammatory Activity in Carrageenan-Induced Pleurisy
Endocrinology, 2000, 141, 1455-1463
2.579Citations (PDF)
474ROLE OF HYPERBARIC OXYGEN EXPOSURE IN REDUCTION OF LIPID PEROXIDATION AND IN MULTIPLE ORGAN FAILURE INDUCED BY ZYMOSAN ADMINISTRATION IN THE RAT
Shock, 2000, 13, 197-203
2.434Citations (PDF)
475The Tyrosine Kinase Inhibitor Tyrphostin AG126 Reduces the Development of Acute and Chronic Inflammation
American Journal of Pathology, 2000, 157, 145-158
3.421Citations (PDF)
476Calpain Inhibitor I Reduces the Development of Acute and Chronic Inflammation
American Journal of Pathology, 2000, 157, 2065-2079
3.467Citations (PDF)
477The protective role of endogenous melatonin in carrageenan‐induced pleurisy in the rat
FASEB Journal, 1999, 13, 1930-1938
0.665Citations (PDF)
478Regulation of prostaglandin production in carrageenan-induced pleurisy melatonin6.955Citations (PDF)
479Beneficial effects of raxofelast (IRFI 016), a new hydrophilic vitamin E-like antioxidant, in carrageenan-induced pleurisy6.351Citations (PDF)
480Beneficial effects of Mn(III)tetrakis (4‐benzoic acid) porphyrin (MnTBAP), a superoxide dismutase mimetic, in zymosan‐induced shock
British Journal of Pharmacology, 1999, 128, 1241-1251
6.340Citations (PDF)
481Protective effects of Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP), a superoxide dismutase mimetic, in paw oedema induced by carrageenan in the rat
Biochemical Pharmacology, 1999, 58, 171-176
5.131Citations (PDF)
482The protective role of endogenous glutathione in carrageenan-induced pleurisy in the rat4.353Citations (PDF)
483Regulation of prostaglandin production by inhibition of poly (ADP-ribose) synthase in carrageenan-induced pleurisy
Life Sciences, 1999, 65, 1297-1304
4.53Citations (PDF)
484IL-6 knock-out mice exhibit resistance to splanchnic artery occlusion shock
Journal of Leukocyte Biology, 1999, 66, 471-480
2.966Citations (PDF)
485Effects of melatonin in a rat model of splanchnic artery occlusion and reperfusion
Shock, 1999, 12, 25
2.43Citations (PDF)
486Protective effect of N-acetylcysteine on multiple organ failure induced by zymosan in the rat
Critical Care Medicine, 1999, 27, 1524-1532
0.546Citations (PDF)
487Protective effects of melatonin in zymosan-activated plasma-induced paw inflammation4.360Citations (PDF)
488Title is missing!2.120Citations (PDF)
489Decoding the regulatory network of microRNAs, lncRNAs, and transcription factors in relapsing-remitting multiple sclerosis: A case-control in silico study
Heliyon, 0, 11, e43854
3.22Citations (PDF)
490Alternative source of stem cells derived from human periodontal ligament: a new treatment for experimental autoimmune encephalomyelitis0.00Citations (PDF)
491Engineered vesiscles from gingival stem cells: a new approach in 3D printed bone tissue regeneration0.01Citations (PDF)
492Moringin Treatment on Mesenchymal Stem Cells from Periodontal Ligament Induces Neural Differentiation0.00Citations (PDF)
493Corrigendum to “Anti-inflammatory and anti-apoptotic effects of fumonisin B1, an inhibitor of ceramide synthase, in a rodent model of splanchnic ischemia and reperfusion injury”3.30Citations (PDF)
494Editorial Expression of Concern: Role of TNF-α in lung tight junction alteration in mouse model of acute lung inflammation4.20Citations (PDF)